Stryker Rejuvenate ABG II Class Action Settlement
The 2016 Settlement Program is for patients who had an ABG II Modular Neck Hip Stem or Rejuvenate Modular Neck Hip Stem implanted in the United States (or at a United States military hospital), subsequently had a surgery to remove the modular hip stem prior to December 19, 2016,You cannot participate in the 2016 Settlement Program if you received an award under the 2014 Settlement Program or if you otherwise resolved your claim
The 2016 Settlement Program also includes those patients who had an ABG II Modular Neck Hip Stem or Rejuvenate Modular Neck Hip Stem implanted in the United States (or at a United States military hospital), but are unable to have a necessary surgery to remove the product prior to December 19, 2016, because they have been deemed to be physically unable to undergo the procedure as indicated by their surgeon.
Up to $300,000
There may be additional benefits and services based on individual cases
Proof of Purchase
Applicants may need to submit certain medical records
In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation,MDL No. 13-2441District Court for the District of Minnesota
In 2014, Stryker Orthopaedics’ counsel and attorneys representing patients affected by Stryker’s voluntary recall of its ABG II Modular Neck Hip Stem and Rejuvenate Modular Neck Hip Stem in June 2012 due to potential risks associated with these products reached a settlement for patients who were revised at the time that the Settlement Program was announced. More recently, the scope of that 2014 Agreement has expanded to include patients who underwent a revision surgery prior to December 19, 2016. This Settlement is a means to resolve eligible patients’ claims in a fair, timely, and efficient manner, regardless of whether they filed a lawsuit. Patients do not need to be represented by an attorney in order to participate in the 2016 Settlement Program.